AdipoSeeds Overview
- Year Founded
-
2016
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$11.6M
- Investors
-
11
AdipoSeeds General Information
Description
Developer of a platelet-making system designed to solve the shortage of platelets in the world, and to create a future where a platelet-related treatment will be cheaply and safely provided. The company's platelet offers a novel technology for making platelets from mesenchymal stem cells without a complex and costly gene transfer along with a new blood supply system, enabling clients of the biotechnology industry with fat-derived platelets for blood products and wound care medicine.
Contact Information
Website
www.adiposeeds.co.jpCorporate Office
- 10th floor, Mita Kokusai Building
- 1-4-28 Mita, Minato-ku
- Tokyo, 108-0073
- Japan
Corporate Office
- 10th floor, Mita Kokusai Building
- 1-4-28 Mita, Minato-ku
- Tokyo, 108-0073
- Japan
AdipoSeeds Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Later Stage VC | 12-Dec-2022 | $11.6M | Completed | Clinical Trials - General | ||
3. Early Stage VC | 16-Oct-2020 | Completed | Clinical Trials - General | |||
2. Seed Round | 01-Nov-2019 | Completed | Startup | |||
1. Early Stage VC | 20-Dec-2017 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AdipoSeeds Patents
AdipoSeeds Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-6714932-B2 | Method for producing vertebrate adipose tissue-derived mesenchymal cell line | Active | 01-Dec-2015 | ||
US-11518982-B2 | Method for manufacturing mesenchymal cell line derived from vertebrate animal adipose tissue | Active | 01-Dec-2015 | ||
US-20200190474-A1 | Method for manufacturing mesenchymal cell line derived from vertebrate animal adipose tissue | Active | 01-Dec-2015 | ||
JP-WO2017094260-A1 | Method for producing vertebrate adipose tissue-derived mesenchymal cell line | Active | 01-Dec-2015 | ||
EP-3385372-A4 | Method for manufacturing mesenchymal cell line derived from vertebrate animal adipose tissue | Active | 01-Dec-2015 | C12N5/0653 |
AdipoSeeds Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
DCI Partners | Venture Capital | Minority | ||
Gemseki | Corporate Venture Capital | Minority | ||
MSF Capital Partners | Corporation | Minority | ||
Nissay Capital | Venture Capital | Minority | ||
SMBC Venture Capital | Corporate Venture Capital | Minority |
AdipoSeeds FAQs
-
When was AdipoSeeds founded?
AdipoSeeds was founded in 2016.
-
Where is AdipoSeeds headquartered?
AdipoSeeds is headquartered in Tokyo, Japan.
-
What industry is AdipoSeeds in?
AdipoSeeds’s primary industry is Discovery Tools (Healthcare).
-
Is AdipoSeeds a private or public company?
AdipoSeeds is a Private company.
-
What is AdipoSeeds’s current revenue?
The current revenue for AdipoSeeds is
. -
How much funding has AdipoSeeds raised over time?
AdipoSeeds has raised $11.6M.
-
Who are AdipoSeeds’s investors?
DCI Partners, Gemseki, MSF Capital Partners, Nissay Capital, and SMBC Venture Capital are 5 of 11 investors who have invested in AdipoSeeds.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »